{"name": "Amakem",
 "permalink": "amakem-nv",
 "crunchbase_url": "http://www.crunchbase.com/company/amakem-nv",
 "homepage_url": "http://www.amakem.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@amakem.com",
 "phone_number": "32-(0)-11-286-982",
 "description": "",
 "created_at": "Tue Sep 06 12:55:36 UTC 2011",
 "updated_at": "Wed Sep 07 03:14:10 UTC 2011",
 "overview": "\u003Cp\u003EAmakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem\u00e2\u20ac\u2122s product pipeline is based on its unique \u00e2\u20ac\u02dcLocalized Drug Action\u00e2\u20ac\u2122 platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0015/2893/152893v1-max-150x150.jpg"],
     [[250,
       75],
      "assets/images/resized/0015/2893/152893v1-max-250x250.jpg"],
     [[343,
       103],
      "assets/images/resized/0015/2893/152893v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac18M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.prnewswire.com/news-releases/amakem-raises-18m-in-a-series-a-round-to-advance-its-ophthalmology-drug-development-programs-129283853.html",
    "source_description": "Amakem Raises \u00e2\u201a\u00ac18m in a Series a Round to Advance its Ophthalmology Drug Development Programs",
    "raised_amount": 18000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Credit Agricole Private Equity",
         "permalink": "credit-agricole-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/3491/23491v3-max-150x150.jpg"],
             [[250,
               68],
              "assets/images/resized/0002/3491/23491v3-max-250x250.jpg"],
             [[450,
               123],
              "assets/images/resized/0002/3491/23491v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vesalius Biocapital Partners",
         "permalink": "vesalius-biocapital-partners",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LRM",
         "permalink": "limburgse-reconversie-maatschappij",
         "image":
          {"available_sizes":
            [[[150,
               111],
              "assets/images/resized/0006/1570/61570v1-max-150x150.jpg"],
             [[181,
               135],
              "assets/images/resized/0006/1570/61570v1-max-250x250.jpg"],
             [[181,
               135],
              "assets/images/resized/0006/1570/61570v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Agoralaan bldg. A bis",
    "address2": "3590 Diepenbeek",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "BEL",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        106],
       "assets/images/resized/0015/2894/152894v1-max-150x150.jpg"],
      [[250,
        177],
       "assets/images/resized/0015/2894/152894v1-max-250x250.jpg"],
      [[450,
        320],
       "assets/images/resized/0015/2894/152894v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}